Home › Myelodysplastic Syndromes › Illinois › Decatur
Myelodysplastic Syndromes clinical trials in Decatur, IL
3 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Decatur (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
RecruitingPhase 1/2
- Research Site, Decatur
About Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.
More about Myelodysplastic Syndromes on MedlinePlus
Myelodysplastic Syndromes trials in other cities
- Houston, TX43 studies
- Baldwin Park, CA26 studies
- Seattle, WA21 studies
- New York City, NY21 studies
- Washington, DC20 studies
- Boston, MA19 studies
- Tampa, FL19 studies
- Miami, FL17 studies
- Columbus, OH14 studies
- Durham, NC14 studies
- Atlanta, GA13 studies
- Chicago, IL13 studies
Other studies in Decatur
- Non-Small Cell Lung Cancer14 studies
- Prostate Cancer12 studies
- Lung Cancer10 studies
- Breast Cancer8 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Acute Myeloid Leukemia7 studies
- Bladder Cancer6 studies
- Pancreatic Cancer6 studies
- Colorectal Cancer6 studies
- Melanoma5 studies
- Oral Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.